Abstract

BackgroundParticle size is thought to be a critical factor affecting the bioavailability of nanoparticles following oral exposure. Nearly all studies of nanoparticle bioavailability focus on characterization of the primary particle size of the material as supplied or as dosed, and not on agglomeration behavior within the gastrointestinal tract, which is presumably most relevant for absorption.MethodsIn the study reported here, snapshots of agglomeration behavior of gold nanospheres were evaluated in vivo throughout the gastrointestinal tract using transmission electron microscopy. Agglomeration state within the gastrointestinal tract was then used to help explain differences in gastrointestinal particle absorption, as indicated by tissue levels of gold detected using inductively coupled plasma mass spectrometry. Mice were dosed (10 mg/kg) with either 23 nm PEG-coated or uncoated gold nanospheres.ResultsTransmission electron microscopy demonstrates that PEG-coated gold nanoparticles can be observed as primary, un-agglomerated particles throughout the gastrointestinal tract and feces of dosed animals. In contrast, uncoated gold nanoparticles were observed to form agglomerates of several hundred nanometers in all tissues and feces. Inductively coupled plasma mass spectrometry shows significantly higher levels of gold in tissues from animals dosed with PEG-coated versus uncoated 23 nm gold nanoparticles. Retention of particles after a single oral gavage was also very high, with all tissues of animals dosed with PEG-coated particles having detectable levels of gold at 30 days following exposure.ConclusionsQualitative observation of these particles in vivo shows that dispersed PEG-coated particles are able to reach the absorptive tissues of the intestine while agglomerated uncoated particles are sequestered in the lumen of these tissues. However, the large differences observed for in vivo agglomeration behavior were not reflected in oral absorption, as indicated by gold tissue levels. Additional factors, such as surface chemistry, may have played a more important role than in vivo particle size and should be investigated further.

Highlights

  • Particle size is thought to be a critical factor affecting the bioavailability of nanoparticles following oral exposure

  • We report here the results of a study using transmission electron microscopy to relate snapshots of agglomeration behavior of gold nanoparticles in the gastrointestinal tract (GIT) and to particle uptake

  • This study suggests that agglomeration behavior and effective particle size within the gastrointestinal tract may not be a significant factor for the oral bioavailability of gold nanomaterials, Figure 5 (See legend on page.)

Read more

Summary

Introduction

Particle size is thought to be a critical factor affecting the bioavailability of nanoparticles following oral exposure. The projected market value for nanotechnology products is expected to exceed $3 trillion this year, with over 1,000 consumer goods currently available containing nanomaterials [1,2] Applications for these materials that may lead to oral exposure are continuing to expand and currently include food additives, food packaging, pharmaceuticals, natural supplements and personal care products [3,4,5,6,7]. Qualitative investigations of particle uptake in the gastrointestinal tract (GIT) have been performed with gold nanoparticles (AuNPs), showing that passive uptake during cell turnover is a primary mechanism of absorption [11] While these studies offer evidence for size-dependent mechanisms of uptake, they provide little quantitative data on the uptake of ingested particles

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call